SVETLANA CHEHET: Open Payments
NPI 1265837892 · NEPTUNE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,056 in 61 payments from 16 companies in 2025. Trend: 2023 $2,137 · 2024 $2,688 · 2025 $1,056
Food & beverage: $957Education: $98
| Company | Payments | Amount |
|---|---|---|
| Organon LLC | 27 | $306 |
| Regeneron Healthcare Solutions, Inc. | 4 | $254 |
| MAYNE PHARMA COMMERCIAL LLC | 7 | $101 |
| GENZYME CORPORATION | 3 | $63 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $50 |
| LEO Pharma Inc. | 3 | $49 |
| UCB, Inc. | 2 | $37 |
| Lilly USA, LLC | 2 | $35 |
| Incyte Corporation | 2 | $34 |
| Amgen Inc. | 2 | $31 |
Products named: DUPIXENT, VTAMA, ADBRY, Bimzelx, TALTZ, Leqselvi, OPZELURA, Otezla.
Industry payments across NJ — which companies pay providers there.
